Source:http://linkedlifedata.com/resource/pubmed/id/10382232
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1999-7-29
|
pubmed:abstractText |
Proliferation of alveolar type II cells is critical for restoration of the integrity of alveolar epithelium in alveolar injuries caused by a number of different aetiologies. Because effects of inflammatory cytokines on the proliferation of alveolar type II cells are not clear, we investigated the effects of interleukin-1 beta (IL-1 beta) on [3H]-thymidine incorporation into DNA in rat alveolar type II cells in primary culture. Interleukin-1 beta enhanced the [3H]-thymidine incorporation dose and time dependently. The increase of [3H]-thymidine incorporation was observed in parallel with increased number of rat alveolar type II cells. The effect of IL-1 beta on [3H]-thymidine incorporation was additive to effects of growth factors which were known to act as mitogenic factors for type II cells. Anti-interleukin-1 beta antibody or IL-1 receptor antagonist partially inhibited the effects of IL-1 beta on [3H]-thymidine incorporation. Their combination completely inhibited the effects of IL-1 beta. In the absence of IL-1 beta, the combination inhibited the [3H]-thymidine incorporation to a level under that in the control. Isolated alveolar type II cells were immunocytochemically stained positive with anti-IL-1 beta antibody. Reverse transcriptase-polymerase chain reaction (RT-PCR) showed the presence of the mRNA for IL-1 beta in cultured alveolar type II cells. These results demonstrate that exogenous IL-1 beta stimulates DNA synthesis in alveolar type II cells and that the cells also produce IL-1 beta endogenously and suggest that endogenous IL-1 beta may mediate basal DNA synthesis of alveolar type II cells.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1323-7799
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
4
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
139-45
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10382232-Animals,
pubmed-meshheading:10382232-Cell Division,
pubmed-meshheading:10382232-Cells, Cultured,
pubmed-meshheading:10382232-DNA Replication,
pubmed-meshheading:10382232-Dose-Response Relationship, Drug,
pubmed-meshheading:10382232-Drug Evaluation, Preclinical,
pubmed-meshheading:10382232-Epithelial Cells,
pubmed-meshheading:10382232-Immunohistochemistry,
pubmed-meshheading:10382232-Interleukin-1,
pubmed-meshheading:10382232-Male,
pubmed-meshheading:10382232-Pulmonary Alveoli,
pubmed-meshheading:10382232-Rats,
pubmed-meshheading:10382232-Rats, Sprague-Dawley,
pubmed-meshheading:10382232-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:10382232-Thymidine,
pubmed-meshheading:10382232-Time Factors
|
pubmed:year |
1999
|
pubmed:articleTitle |
Effects of interleukin-1 beta on DNA synthesis in rat alveolar type II cells in primary culture.
|
pubmed:affiliation |
Department of Internal Medicine, Kanazawa Medical University, Ishikawa, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|